PTHS · Pelthos Therapeutics Inc. · Holdings

$19.59 +0.89 (+4.76%) At close · Oct 22

Market Cap

$71.59M

3.83M

Volume · Oct 22 79.8K Avg daily vol (3M) 61.99K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of PTHS: 13F, 13D and 13G, insiders and funds →

The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.

Quarter:

Holders: 24

Total Value: $37,392,280

Total Shares: 1,323,163

Institutional Ownership Trend

11 quarters

Holder Concentration

Across 24 13F filers

Top Holder

24.9%

of institutional value

Top 5

82.3%

of institutional value

Top 10

93.3%

of institutional value

HHI

1,668

Moderately concentrated

Who Holds PTHS

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 24 filers, like-for-like change +45.0%; actively managed books +49.4%; index-like books +15.7%.

Holder type	Share	Filers	Change	New	Exited
Registered adviser	43.9%	10	+10.9%	3	2
Exempt adviser	23.5%	2	+2.6%	0	0
Bank	0.9%	4	+1474.2%	3	1
Holding company	1.4%	2	+41.2%	1	0
Unknown	30.3%	6	+455.3%	3	0

Style	Share	Filers	Change	New	Exited
Index-like	10.3%	5	+15.7%	2	0
Systematic-like	8.8%	2	+43.0%	1	0
Concentrated	57.0%	7	+90.1%	2	1
Diversified active	23.9%	10	0.0%	5	2
Not measured	0.0%	0	—	0	0
Unknown	0.0%	0	—	0	0

Turnover	Share	Filers	Change	New	Exited
Low turnover	4.1%	7	+41.1%	4	1
Medium turnover	4.8%	5	+15.5%	2	2
High turnover	83.0%	10	+53.4%	4	0
Unknown	8.1%	2	+4.0%	0	0
Not measured	0.0%	0	—	0	0

Holding horizon	Share	Filers	Change	New	Exited
Short horizon	35.3%	5	+249.2%	1	0
Medium horizon	48.3%	6	+1.7%	1	1
Long horizon	3.3%	9	+145.2%	6	2
Unknown	13.1%	4	+30.6%	2	0
Not measured	0.0%	0	—	0	0

13F book size	Share	Filers	Change	New	Exited
Under $1B	48.9%	7	+6.9%	2	1
$1B to $10B	39.5%	7	+180.0%	3	0
$10B to $100B	0.0%	1	-97.9%	0	1
$100B or more	11.6%	9	+29.5%	5	1
Not measured	0.0%	0	—	0	0

Client base	Share	Filers	Change	New	Exited
Individuals and high net worth	0.8%	2	+430.0%	1	2
Pooled investment vehicles	34.7%	6	+10.9%	2	0
Registered funds and BDCs	8.4%	2	+3.1%	0	0
Unknown	56.1%	14	+91.1%	7	1

Private funds	Share	Filers	Change	New	Exited
Hedge funds	35.1%	7	+10.8%	2	0
Private funds, type not stated	23.0%	1	+2.7%	0	0
No private funds	9.2%	4	+10.7%	1	2
Unknown	32.6%	12	+402.1%	7	1

Location	Share	Filers	Change	New	Exited
United States	75.2%	17	+66.9%	7	3
Outside the US	24.8%	7	+3.7%	3	0

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

24 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders

4.17% of filers hold it in their top 10

Mar 31, 2026: 1

Holders above 5%

median weight 0.012%

Mar 31, 2026: 0

Crowding

31.6%

of shares outstanding, 84th percentile

Mar 31, 2026: 21.3%

Private-fund advisers

22.1%

of shares outstanding

Institutional ownership

38.1%

97.7% of the estimated free float

Top 10 holders

93.3%

of 13F shares, Herfindahl 0.167

Active holders

+49.4%

like-for-like share change of active filers

5% stakes on record

2 13D, 3 13G (2 institutional, 1 passive, 0 exempt)

How long holders have held it value-weighted 2.9 quarters

Under 1 year 44.6% 1 to 3 years 55.4% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost

$26.13

estimated per share

Mar 31, 2026: $28.29

Quarter-end price

$28.26

implied by 13F values

Estimated gain or loss

+8.1%

price against the estimated cost

Estimated at a loss

7.87%

of costed 13F value

Estimated cost covers 36.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies PTHS's active holders also own, quarter ended Jun 30, 2026

#	Company	Shared holders	Similarity
1	SPRB Spruce Biosciences, Inc.	5	0.505
2	CNTB Connect Biopharma Holdings Ltd	3	0.342
3	HELP Helus Pharma Inc.	4	0.322
4	RLMD Relmada Therapeutics, Inc.	4	0.302
5	VSTM Verastem, Inc.	3	0.267
6	RCUS Arcus Biosciences, Inc.	3	0.236
7	ARDX Ardelyx, Inc.	3	0.231
8	BIOA BioAge Labs, Inc.	3	0.214
9	VRDN Viridian Therapeutics, Inc.\DE	3	0.194
10	RARE Ultragenyx Pharmaceutical Inc.	3	0.189

Shareholder Targets

13F filers that own its peers but not PTHS, quarter ended Jun 30, 2026

Found through its holder-overlap peers: SPRB, CNTB, HELP, RLMD, VSTM, RCUS, ARDX, BIOA, VRDN, RARE, VERA, ELVN, COGT, CNQ. 1,147 filers in all.

#	Filer	In peers	Of book	Largest peers
1	Capital World Investors Adviser, Diversified active	$8,609,452,982 1 held	1.02%	CNQ
2	FMR LLC Holding company, Diversified active	$4,615,685,226 13 held	0.200%	CNQ, COGT, ELVN
3	Capital Research Global Investors Adviser, Diversified active	$4,584,675,335 1 held	0.640%	CNQ
4	BANK OF MONTREAL /CAN/ Bank, Diversified active	$2,562,772,955 3 held	0.970%	CNQ, COGT, RCUS
5	GOLDMAN SACHS GROUP INC Holding company, Index-like	$2,307,288,107 13 held	0.240%	CNQ, COGT, VERA
6	PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active	$1,687,656,934 12 held	0.170%	CNQ, COGT, VERA
7	CANADA PENSION PLAN INVESTMENT BOARD Non-US, Diversified active	$1,527,698,071 4 held	0.850%	CNQ, ELVN, VERA
8	TD Asset Management Inc Unknown, Diversified active	$1,249,362,434 6 held	1.09%	CNQ, ELVN, VERA
9	HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND Non-US, Diversified active	$1,216,331,400 1 held	1.78%	CNQ
10	CIBC WORLD MARKET INC. Unknown, Diversified active	$1,199,657,936 1 held	2.02%	CNQ

Fund Ownership of PTHS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 2.97% of shares outstanding.

Fund type	Of shares outstanding	Change	Shares	Funds
Index funds	0.38%	+0.04 pp	14,486	5
Index ETFs	2.59%	+0.21 pp	99,127	3
Active ETFs	0.00%	0.00 pp	0	0
Active funds	0.01%	+0.01 pp	333	1
Unclassified	0.00%	0.00 pp	0	0
All registered funds	2.98%	+0.26 pp	113,946	9

How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Holder type: Registered adviser 10 Exempt adviser 2 Bank 4 Holding company 2 Unknown 6

Showing 24 of 24

All Common Calls Puts

Compact Export CSV

Holder

Value (USD)

% of 13F

AIGH Capital Management LLC

$9,300,309

24.87%

329,098

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Worth Venture Partners, LLC	80,674	$2,279,847	24.5%	Other
Held directly	248,424	$7,020,462	75.5%	Sole

Murchinson Ltd.

$8,599,574

23.00%

304,302

Ikarian Capital, LLC

$7,251,459

19.39%

256,598

BOOTHBAY FUND MANAGEMENT, LLC

$2,881,841

7.71%

101,976

VANGUARD CAPITAL MANAGEMENT LLC

$2,745,006

7.34%

97,134

CANTOR FITZGERALD, L. P.

$1,077,355

2.88%

38,123

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Cantor Fitzgerald & Co.	38,123	$1,077,355	100.0%	Defined

J. Goldman & Co LP

$1,075,999

2.88%

38,075

DIADEMA PARTNERS LP

$700,084

1.87%

24,773

WEXFORD CAPITAL LP

$632,006

1.69%

22,364

Knott David M Jr

$623,782

1.67%

22,073

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Dorset Partners LLC	22,073	$623,782	100.0%	Defined

CITADEL ADVISORS LLC

$425,199

1.14%

15,046

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Citadel Securities GP LLC	15,046	$425,199	100.0%	Defined

GEODE CAPITAL MANAGEMENT, LLC

$414,008

1.11%

14,650

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
GEODE CAPITAL MANAGEMENT TRUST COMPANY, LLC	2,908	$82,180	19.8%	Defined
Held directly	11,742	$331,828	80.2%	Defined

Pale Fire Capital SE

$365,090

0.98%

12,919

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Barta Jan joint	12,919	$365,090	100.0%	Defined

1492 Capital Management LLC

$293,338

0.78%

10,380

VANGUARD FIDUCIARY TRUST CO

$279,010

0.75%

9,873

STATE STREET CORP

$276,948

0.74%

9,800

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
STATE STREET GLOBAL ADVISORS TRUST COMPANY	9,800	$276,948	100.0%	Defined

Persistent Asset Partners Ltd

$169,757

0.45%

6,007

BlackRock, Inc.

$150,455

0.40%

5,324

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
BlackRock Investment Management, LLC	333	$9,410	6.3%	Sole
BlackRock Fund Advisors	4,991	$141,045	93.7%	Sole

UBS Group AG

$62,652

0.17%

2,217

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
UBS AG	2,217	$62,652	100.0%	Defined

China Universal Asset Management Co., Ltd.

$61,041

0.16%

2,160

Tower Research Capital LLC (TRC)

$5,793

0.02%

205

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Latour Trading LLC (Latour)	205	$5,793	100.0%	Defined

Farther Finance Advisors, LLC

$840

0.00%

BARCLAYS PLC

$565

0.00%

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
BARCLAYS CAPITAL INC.	20	$565	100.0%	Defined

ROYAL BANK OF CANADA

$169

0.00%

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
RBC Capital Markets, LLC	6	$169	100.0%	Defined

Key facts CIK 1919246 CUSIP 171126204 13F (30d) 1 filings 1 filers Visit website Investor relations